ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BRUCE MARTIN MD

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,952Medicare Part D Prescriptions Filled, Including Refills

Rank: 586 out of 2087

$538K Total Retail Price of All Prescriptions

Rank: 707 out of 2087

504 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Ohio
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 410 323 79 1 2
SIMVASTATIN 386 340 83 2 3
LISINOPRIL 344 280 75 3 1
OMEPRAZOLE 326 205 64 4 5
AMLODIPINE BESYLATE 293 277 59 5 4
ATORVASTATIN CALCIUM 238 223 52 6 6
FUROSEMIDE 238 192 39 6 7
METFORMIN HCL 226 174 47 8 9
ATENOLOL 225 183 47 9 16
PRAVASTATIN SODIUM 224 219* 55 10 13
LOSARTAN POTASSIUM 218 213* 55 11 15
ALENDRONATE SODIUM 218 161 43 11 35
METOPROLOL TARTRATE 205 188 44 13 8
POTASSIUM CHLORIDE 175 138 29 14 17
HYDROCHLOROTHIAZIDE 173 157 45 15 11
RANITIDINE HCL 157 110 30 16 60
METFORMIN HCL ER 144 139* 28 17 65
WARFARIN SODIUM 141 128 34 18 12
METOPROLOL SUCCINATE 109 109 24 19 20
OXYBUTYNIN CHLORIDE ER 107 41 15 20 77
NEXIUM 106 41 16 21 33
CITALOPRAM HBR 101 69 25 22 21
TAMSULOSIN HCL 96 84 23 23 28
LOSARTAN-HYDROCHLOROTHIAZIDE 92 92 26 24 47
GLIMEPIRIDE 89 84* 20 25 34
SYNTHROID 83 83 18 26 54
SERTRALINE HCL 81 45 17 27 22
ALLOPURINOL 76 76 17 28 27
CLOPIDOGREL 76 76 11 28 18
TRAMADOL HCL 74 69* 21 30 19
TRIAMTERENE-HCTZ 73 73 16 31 41
MONTELUKAST SODIUM 73 60 14 31 53
PAROXETINE HCL 72 54 14 33 66
FLUTICASONE PROPIONATE 69 25 16 34 38
MELOXICAM 66 66 16 35 44
CARVEDILOL 66 51 13 35 23
DIVALPROEX SODIUM 66 <11 <11 35 78
CARBAMAZEPINE 64 <11 <11 38 185
DOXAZOSIN MESYLATE 60 60 12 39 82
LAMOTRIGINE 58 <11 <11 40 182
MINOCYCLINE HCL 56 <11 <11 41 363
CELEBREX 55 55 17 42 87
DONEPEZIL HCL 55 <11 <11 42 26
POLYETHYLENE GLYCOL 3350 50 <11 <11 44 72
DILTIAZEM 24HR ER 50 <11 <11 44 98
LOVASTATIN 50 <11 <11 44 43
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.